In summary, our study demonstrates that high expression of CPNE3 is associated with advanced TNM stage and a poor prognosis in patients with NSCLC, revealing that the interaction between CPNE3 and RACK1 can activate the c‐MET signalling pathway. The gene discussed is CPNE3; the disease is non-small cell lung carcinoma.